Close Menu

James Le Fanu, a physician by trade, suggests in a Prospect magazine editorial that "for science this is both the best and the worst of times." It is the "best," he says, because "its research institutions have never been so impressive, its funding never more lavish." But the "worst," he adds, because the scientific achievements "of the recent past have been rather disappointing," when compared with those from the beginning of the 20th century.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.